InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（15 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
15
T+90 胜率
100%
T+90 平均收益
+60.4%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Peetz Christopher, 董事长兼首席执行官. Director active across 4 companies, notably Mirum Pharmaceuticals, Inc.. In total, 41 reports have been logged. Breakdown: 2 buys · 15 sells. Total volume traded: €6m. History available since 10 May 2021. The latest transaction was filed on 10 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Peetz Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报41 总计
20,000 股@ US$2.9360.0010% mcap0.7% 占其流量Common StockSEC:0001614740-26-000012:0
11,683 股@ US$98.510.019% mcap14.7% 占其流量Common StockSEC:0001614740-26-000012:1
6,017 股@ US$99.250.0097% mcap7.6% 占其流量Common StockSEC:0001614740-26-000012:2
2,300 股@ US$100.140.0037% mcap2.9% 占其流量Common StockSEC:0001614740-26-000012:3
4,315 股0Common StockSEC:0001628280-26-048655:0
20,000 股@ US$2.9360.0007% mcap1.3% 占其流量Common StockSEC:0001614740-26-000011:0
12,134 股@ US$121.650.019% mcap33.0% 占其流量Common StockSEC:0001614740-26-000011:1
4,181 股@ US$122.340.0065% mcap11.4% 占其流量Common StockSEC:0001614740-26-000011:2
1,975 股@ US$123.740.0031% mcap5.5% 占其流量Common StockSEC:0001614740-26-000011:3
1,710 股@ US$124.790.0027% mcap4.8% 占其流量Common StockSEC:0001614740-26-000011:4
25,000 股Common StockSEC:0001614740-26-000009:0
9,108 股@ US$103.303515.5% 占其流量Common StockSEC:0001614740-26-000007:0
12,500 股Common StockSEC:0001614740-26-000003:0
12,797 股Common StockSEC:0001614740-26-000002:0
21,070 股0Common StockSEC:0001614740-26-000001:0
19,133 股@ US$19.247.3% 占其流量Common StockSEC:0001614740-25-000005:0
40,000 股@ US$2.9362.5% 占其流量Common StockSEC:0001415889-25-021521:0
40,000 股@ US$2.9362.5% 占其流量Common StockSEC:0001415889-25-021350:0
50,000 股Common StockSEC:0001415889-25-008556:0
40,000 股@ US$2.9366.6% 占其流量Common StockSEC:0001415889-25-006524:0
9,102 股@ US$48.222524.9% 占其流量Common StockSEC:0001415889-25-002981:0
12,500 股Common StockSEC:0001415889-25-002134:0
7,489 股@ US$42.815317.9% 占其流量Common StockSEC:0001415889-25-001143:0
65 股@ US$21.0460.1% 占其流量Common StockSEC:0001415889-24-026868:0
34,013 股@ US$2.9365.4% 占其流量Common StockSEC:0001415889-24-020053:0
41 条申报中的 25 条
About Peetz Christopher
Peetz Christopher is Président-Directeur Général. He is associated with Mirum Pharmaceuticals, Inc. as CHIEF EXECUTIVE OFFICER, and with ALPINE IMMUNE SCIENCES, INC. and Alpine Immune Sciences, INC. as Director. Across 36 filings in total, the 36 sampled filings cover the period from 2021-05-12 to 2026-07-08, with buy amounts of EUR 106099 and sell amounts of EUR 4192861, and the most frequent transaction nature is Cession.
